General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey

A dose non-inferiority study comparing 100 mg, 300 mg and 600 mg of aspirin for cancer prevention among Lynch Syndrome carriers is underway (Colorectal Adenoma/Carcinoma Prevention Programme trial 3, CaPP3). To guide implementation of the findings, we investigated general practitioner (GP) attitudes...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Samuel G., Foy, Robbie, McGowan, Jennifer, Kobayashi, Lindsay C., Burn, John, Brown, Karen, Side, Lucy, Cuzick, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603645/
https://www.ncbi.nlm.nih.gov/pubmed/28434157
http://dx.doi.org/10.1007/s10689-017-9986-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603645/
https://www.ncbi.nlm.nih.gov/pubmed/28434157
http://dx.doi.org/10.1007/s10689-017-9986-9

Ejemplares similares